You are here: Industry Insights > Market News > UAE approves Moderna COVID-19 vaccine for emergency use

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

New Products

Avatrombopag Maleate

BioHub® Magnetic Separator

Avatrombopag

Ursodeoxycholic acid

Troxerutin

CytoLinX® BRTF Single-use Top-driven Bioreactor Bag

UAE approves Moderna COVID-19 vaccine for emergency use

firstwordpharmaJuly 05, 2021

Tag: UAE , COVID-19 , Vaccine

Favorites

The United Arab Emirates has approved Moderna’s COVID-19 vaccine for emergency use, the health ministry said in a statement on state news agency WAM on Sunday, as reported by Fidelity.

UAE approves Moderna COVID-19 vaccine for emergency use

It is the fifth vaccine to receive such approval by the Gulf Arab state.

Around 73.8% of the UAE's population has received one vaccine dose while 63.7% are fully vaccinated, according to the health ministry.

Previous:U.S. to ship 4 million vaccine doses to Indonesia 'as soon as possible'

Next:Large-scale drug analysis reveals potential new COVID-19 antivirals

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

PharmaSourcesNovember 22, 2024

Sartorius Stedim Biotech, a leading partner of the biopharmaceutical industry, today opened its new Center for Bioprocess Innovation in Marlborough, Massachusetts.

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Biotech NewswireNovember 20, 2024

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

PR NEWSWIRENovember 20, 2024

UAE approves Moderna COVID-19 vaccine for emergency use | Pharmasources.com

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

Nurah EkhlaqueNovember 19, 2024

Discover how AI in pharmacovigilance improves drug safety by predicting risks, identifying harmful interactions, and enhancing patient outcomes.

You may like
More>>

Influenza Vaccine（Split Virion）,Inactivated，Quadrivalent

Hualan's Trivalent Flu Vaccine

Influenza Vaccine (Split virion)

Hualan-Inactivated Influenza Vaccine(Split Virion) manufactured by Hualan Bio

Hualan Influenza Vaccine (Split virion)

*trivalent flu vaccine

High-standard and high quality Influenza Vaccine (Split virion), inactivated

Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Hualan

Hualan bio Influenza A (H1N1) Vaccine, (Split, Inactivated)by Hualan biological

Hualan Biological Influenza Vaccine

UAE approves Moderna COVID-19 vaccine for emergency use

Related News

Sartorius Stedim Biotech Opens New Center for Bioprocess Innovation in Marlborough, USA

BioPharmaSpec Announces Three New Facilities in Freiburg, Bergamo and Vilnius

Rona Therapeutics Presented Positive Phase 1 Results of RN0191, a Novel siRNA Therapy Targeting PCSK9, at the 2024 American Heart Association (AHA) Scientific Sessions

AI in Pharmacovigilance: Predicting & Preventing Drug Risks

You may likeMore>>

You may like
More>>